Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus

PHASE3CompletedINTERVENTIONAL

Enrollment

771

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions

Bacterial Pneumonia

Interventions

DRUG

Telavancin

Telavancin 10 mg/kg/day IV for up to 21 days

DRUG

Vancomycin

Vancomycin 1 Gm administered every 12 hrs IV for up to 21 days

Trial Locations (1)

Sheba Medical Center, Infectious Disease Unit, Tel Litwinsky